Garry Pairaudeau

Direttore Tecnico/Scientifico/R&S presso Exscientia AI Ltd.

58 anni

Health Technology

Consumer Services

Posizioni attive di Garry Pairaudeau

Società	Posizione	Inizio	Fine
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom.	Direttore Tecnico/Scientifico/R&S	01/11/2020	-

Società	Posizione	Inizio	Fine
EXSCIENTIA PLC	Direttore Tecnico/Scientifico/R&S	01/11/2020	30/06/2023
ASTRAZENECA PLC	Corporate Officer/Principal	01/01/2014	01/11/2020

The University of Southampton

Doctorate Degree

Distribuzione geografica

Regno Unito

Posizioni

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Doctorate Degree	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
EXSCIENTIA PLC	Health Technology
ASTRAZENECA PLC	Health Technology

Aziende private	1
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom.	Health Technology

Aziende private

Health Technology